Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379966168> ?p ?o ?g. }
- W4379966168 endingPage "529" @default.
- W4379966168 startingPage "521" @default.
- W4379966168 abstract "To analyze the clinicopathological features, molecular changes and prognostic factors in angioimmunoblastic T-cell lymphoma (AITL).Sixty-one cases AITL diagnosed by Department of Pathology of Peking University Cancer Hospital were collected with their clinical data. Morphologically, they were classified as typeⅠ[lymphoid tissue reactive hyperplasia (LRH) like]; typeⅡ[marginal zone lymphoma(MZL)like] and type Ⅲ [peripheral T-cell lymphoma, not specified (PTCL-NOS) like]. Immunohistochemical staining was used to evaluate the presence of follicular helper T-cell (TFH) phenotype, proliferation of extra germinal center (GC) follicular dendritic cells (FDCs), presence of Hodgkin and Reed-Sternberg (HRS)-like cells and large B transformation. The density of Epstein-Barr virus (EBV) + cells was counted with slides stained by Epstein-Barr virus encoded RNA (EBER) in situ hybridization on high power field (HPF). T-cell receptor / immunoglobulin gene (TCR/IG) clonality and targeted exome sequencing (TES) test were performed when necessary. SPSS 22.0 software was used for statistical analysis.Morphological subtype (%): 11.4% (7/61) cases were classified as type Ⅰ; 50.8% (31/61) as type Ⅱ; 37.8% (23/61) as type Ⅲ. 83.6% (51/61) cases showed classical TFH immunophenotype. With variable extra-GC FDC meshwork proliferation (median 20.0%); 23.0% (14/61) had HRS-like cells; 11.5% (7/61) with large B transformation. 42.6% (26/61) of cases with high counts of EBV. 57.9% (11/19) TCR+/IG-, 26.3% (5/19) TCR+/IG+, 10.5% (2/19) were TCR-/IG-, and 5.3% (1/19) TCR-/IG+. Mutation frequencies by TES were 66.7% (20/30) for RHOA, 23.3% (7/30) for IDH2 mutation, 80.0% (24/30) for TET2 mutation, and 33.3% (10/30) DNMT3A mutation. Integrated analysis divided into four groups: (1) IDH2 and RHOA co-mutation group (7 cases): 6 cases were type Ⅱ, 1 case was type Ⅲ; all with typical TFH phenotype; HRS-like cells and large B transformation were not found; (2) RHOA single mutation group (13 cases): 1 case was type Ⅰ, 6 cases were type Ⅱ, 6 cases were type Ⅲ; 5 cases without typical TFH phenotype; 6 cases had HRS-like cells, and 2 cases with large B transformation. Atypically, 1 case showed TCR-/IG-, 1 case with TCR-/IG+, and 1 case with TCR+/IG+; (3) TET2 and/or DNMT3A mutation alone group (7 cases): 3 cases were type Ⅱ, 4 cases were type Ⅲ, all cases were found with typical TFH phenotype; 2 cases had HRS-like cells, 2 cases with large B transformation, and atypically; (4) non-mutation group (3 cases), all were type Ⅱ, with typical TFH phenotype, with significant extra-GC FDC proliferation, without HRS-like cells and large B transformation. Atypically, 1 case was TCR-/IG-. Univariate analysis confirmed that higher density of EBV positive cell was independent adverse prognostic factors for both overall survival (OS) and progression free survival(PFS), (P=0.017 and P=0.046).Pathological diagnoses of ALTL cases with HRS-like cells, large B transformation or type Ⅰ are difficult. Although TCR/IG gene rearrangement test is helpful but still with limitation. TES involving RHOA, IDH2, TET2, DNMT3A can robustly assist in the differential diagnosis of those difficult cases. Higher density of EBV positive cells counts in tumor tissue might be an indicator for poor survival." @default.
- W4379966168 created "2023-06-10" @default.
- W4379966168 creator A5019045093 @default.
- W4379966168 creator A5030766348 @default.
- W4379966168 creator A5034781062 @default.
- W4379966168 creator A5035045150 @default.
- W4379966168 creator A5050479206 @default.
- W4379966168 creator A5059916277 @default.
- W4379966168 creator A5067171110 @default.
- W4379966168 creator A5072793694 @default.
- W4379966168 creator A5078167666 @default.
- W4379966168 creator A5078269576 @default.
- W4379966168 date "2023-06-18" @default.
- W4379966168 modified "2023-09-25" @default.
- W4379966168 title "[Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma]." @default.
- W4379966168 cites W1994372389 @default.
- W4379966168 cites W2030346687 @default.
- W4379966168 cites W2053067769 @default.
- W4379966168 cites W2069271377 @default.
- W4379966168 cites W2310716991 @default.
- W4379966168 cites W2391782924 @default.
- W4379966168 cites W2405754855 @default.
- W4379966168 cites W2411712926 @default.
- W4379966168 cites W2599834292 @default.
- W4379966168 cites W2610939428 @default.
- W4379966168 cites W2752283479 @default.
- W4379966168 cites W2772214850 @default.
- W4379966168 cites W2796334411 @default.
- W4379966168 cites W2927193301 @default.
- W4379966168 cites W2991426900 @default.
- W4379966168 cites W2995009823 @default.
- W4379966168 cites W2996018203 @default.
- W4379966168 cites W3043913681 @default.
- W4379966168 cites W4200530009 @default.
- W4379966168 cites W4206071902 @default.
- W4379966168 cites W4233431843 @default.
- W4379966168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37291929" @default.
- W4379966168 hasPublicationYear "2023" @default.
- W4379966168 type Work @default.
- W4379966168 citedByCount "0" @default.
- W4379966168 crossrefType "journal-article" @default.
- W4379966168 hasAuthorship W4379966168A5019045093 @default.
- W4379966168 hasAuthorship W4379966168A5030766348 @default.
- W4379966168 hasAuthorship W4379966168A5034781062 @default.
- W4379966168 hasAuthorship W4379966168A5035045150 @default.
- W4379966168 hasAuthorship W4379966168A5050479206 @default.
- W4379966168 hasAuthorship W4379966168A5059916277 @default.
- W4379966168 hasAuthorship W4379966168A5067171110 @default.
- W4379966168 hasAuthorship W4379966168A5072793694 @default.
- W4379966168 hasAuthorship W4379966168A5078167666 @default.
- W4379966168 hasAuthorship W4379966168A5078269576 @default.
- W4379966168 hasConcept C142724271 @default.
- W4379966168 hasConcept C147483822 @default.
- W4379966168 hasConcept C159654299 @default.
- W4379966168 hasConcept C196166836 @default.
- W4379966168 hasConcept C203014093 @default.
- W4379966168 hasConcept C204232928 @default.
- W4379966168 hasConcept C2522874641 @default.
- W4379966168 hasConcept C2776090121 @default.
- W4379966168 hasConcept C2776365654 @default.
- W4379966168 hasConcept C2777891184 @default.
- W4379966168 hasConcept C2778453870 @default.
- W4379966168 hasConcept C2779338263 @default.
- W4379966168 hasConcept C2780117679 @default.
- W4379966168 hasConcept C2781375147 @default.
- W4379966168 hasConcept C3753494 @default.
- W4379966168 hasConcept C67662055 @default.
- W4379966168 hasConcept C71924100 @default.
- W4379966168 hasConcept C86803240 @default.
- W4379966168 hasConcept C8891405 @default.
- W4379966168 hasConcept C96926380 @default.
- W4379966168 hasConceptScore W4379966168C142724271 @default.
- W4379966168 hasConceptScore W4379966168C147483822 @default.
- W4379966168 hasConceptScore W4379966168C159654299 @default.
- W4379966168 hasConceptScore W4379966168C196166836 @default.
- W4379966168 hasConceptScore W4379966168C203014093 @default.
- W4379966168 hasConceptScore W4379966168C204232928 @default.
- W4379966168 hasConceptScore W4379966168C2522874641 @default.
- W4379966168 hasConceptScore W4379966168C2776090121 @default.
- W4379966168 hasConceptScore W4379966168C2776365654 @default.
- W4379966168 hasConceptScore W4379966168C2777891184 @default.
- W4379966168 hasConceptScore W4379966168C2778453870 @default.
- W4379966168 hasConceptScore W4379966168C2779338263 @default.
- W4379966168 hasConceptScore W4379966168C2780117679 @default.
- W4379966168 hasConceptScore W4379966168C2781375147 @default.
- W4379966168 hasConceptScore W4379966168C3753494 @default.
- W4379966168 hasConceptScore W4379966168C67662055 @default.
- W4379966168 hasConceptScore W4379966168C71924100 @default.
- W4379966168 hasConceptScore W4379966168C86803240 @default.
- W4379966168 hasConceptScore W4379966168C8891405 @default.
- W4379966168 hasConceptScore W4379966168C96926380 @default.
- W4379966168 hasIssue "3" @default.
- W4379966168 hasLocation W43799661681 @default.
- W4379966168 hasOpenAccess W4379966168 @default.
- W4379966168 hasPrimaryLocation W43799661681 @default.
- W4379966168 hasRelatedWork W2005406254 @default.
- W4379966168 hasRelatedWork W2020093028 @default.
- W4379966168 hasRelatedWork W2028805184 @default.